Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 16, 2015
BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 27,...
-
Jan 8, 2015
BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its first fiscal quarter 2015 earnings conference call on Thursday, February 5, 2015, at 8:00...
-
Jan 7, 2015First-of-its-kind medication management solution for manual IV bolus injections expected to be available commercially in spring 2015
BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has cleared...
-
Jan 7, 2015
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the 33(rd) Annual J. P. Morgan Healthcare Conference on...
-
Dec 9, 2014American Association for Respiratory Care (AARC) Presents Award at Annual Congress
LAS VEGAS, Dec. 9, 2014 /PRNewswire/ – CareFusion (NYSE: CFN), a leading global medical technology company, was presented today with the Zenith Award from the American Association for...
-
Dec 8, 2014CareFusion Launches New Innovations For Enhanced Medication Management Across Multiple Care SettingsNew Solutions from Pharmacy to Bedside Help Support Hospitals and Extend to Outpatient Care Settings
ANAHEIM, Calif., Dec. 8, 2014 /PRNewswire/ – At the 49th Annual American Society of Health-system Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition, CareFusion (NYSE:CFN) announced new...
-
Dec 8, 2014
ANAHEIM, Calif., Dec. 8, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, and Medacist Solutions Group, LLC (Medacist), the leader in drug diversion...
- Dec 8, 2014Exhibit Offers Experiential View of BD's Robust Portfolio from Preparation to Administration
BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, is presenting its comprehensive solutions for the hospital pharmacy during the...
-
Dec 8, 2014
Becton, Dickinson and Company (NYSE: BDX) ("BD") and CareFusion Corporation (NYSE: CFN) ("CareFusion") today announced that CareFusion expects to hold a special meeting on January 21, 2015 for...
-
Dec 4, 2014
Becton, Dickinson and Company (NYSE: BDX) ("BD") announced today its intention to offer senior unsecured notes under a shelf registration statement on Form S-3 (File No. 333-183059) on file with...
-
Dec 1, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that the company's presentation at the 26(th) Annual Piper Jaffray Healthcare...
-
Nov 26, 2014BD Honored with Partner of the Year Award for Leading Green Power Use
FRANKLIN LAKES, N.J., November 26, 2014 – BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it has received a 2014 Green Power Leadership...
-
Nov 20, 2014
Becton, Dickinson and Company (NYSE: BDX) ("BD") and CareFusion Corporation (NYSE: CFN) ("CareFusion") today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements...
-
Nov 6, 2014Revenue increased 11 percent to $922 million
SAN DIEGO, Nov. 6, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its first quarter of fiscal 2015, ended...
-
Nov 4, 2014-- Reports fourth quarter adjusted diluted earnings per share from continuing operations of $1.68. This represents growth of 13.0 percent on a currency-neutral basis, or 9.1 percent including the unfavorable impact of foreign currency. Reported diluted earnings per share from continuing operations for the fourth quarter were $1.53.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.202 billion for the fourth fiscal quarter ended September 30,...
-
Oct 13, 2014Transaction Advances BD’s Entry into Next Generation Sequencing Market
FRANKLIN LAKES, N.J., October 13, 2014 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a...
-
Oct 5, 2014Combination of Complementary Portfolios Creates Global Leader in Medication Management and Patient Safety Solutions
BD (NYSE: BDX) and CareFusion (NYSE: CFN) announced today a definitive agreement under which BD will acquire CareFusion for $58.00 per share in cash and stock, or a total of $12.2 billion, to...
-
Sep 23, 2014Point-of-care CD4 analysis system tailored to meet the needs of resource-limited settings
BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the World Health Organization (WHO) has issued a...
-
Sep 4, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Morgan Stanley Global Healthcare Conference on Monday,...
-
Aug 8, 2014Sedation Analytics Application Combines Infusion and Ventilator Data to Help Ensure Compliance with Sedation Best Practices for Ventilated Patients
SAN DIEGO, CA, Aug. 8, 2014 – CareFusion (NYSE:CFN), a leading global medical technology company, today announced the availability of a new capability on the CareFusion Respiratory Knowledge...
-
Aug 7, 2014Fourth quarter revenue of $1.12 billion, up 24 percent; Fiscal 2014 revenue of $3.84 billion, up 8 percent.
SAN DIEGO, Aug. 7, 2014/PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported results for the quarter and fiscal year ended June 30, 2014,...
-
Aug 6, 2014The only pen needle with patented dual needle shields for enhanced convenience and safety is latest BD innovation for insulin injection
FRANKLIN LAKES, N.J., August 6, 2014 – BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the retail pharmacy...
-
Aug 4, 2014Total Nucleic Acid Reagents Now Available Worldwide - Streamlined Workflow for In-House Developed Assays
BD Diagnostics, a segment of leading global medical technology company BD (Becton, Dickinson, and Company) (NYSE: BDX), announced today the availability of the Total Nucleic Acid (TNA) suite of...
-
Jul 31, 2014ChloraPrep 1 mL Applicator Provides Additional Option to Proven Portfolio of Patient Skin Preparation Products
SAN DIEGO, July 31, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced the launch of its ChloraPrep® 1 mL applicator, the newest addition to...
-
Jul 31, 2014- Announces revenues of $2.157 billion, an increase of 5.1 percent, or 4.6 percent on a foreign currency-neutral basis.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.157 billion for the third fiscal quarter ended June 30, 2014,...
-
Jul 28, 2014Assays bring an innovative solution to microbiology and molecular labs
BD Diagnostics, a segment of BD (Becton, Dickinson and Company), (NYSE: BDX) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration for the BD ProbeTec(TM)...
-
Jul 22, 2014
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 54.5 cents per common share payable on September 30, 2014 to holders of record on...
-
Jul 10, 2014
SAN DIEGO, CA July 10, 2014 /PRNewswire/ – CareFusion Corporation (NYSE: CFN) today announced plans to release fourth quarter and fiscal 2014 results on Thursday, Aug. 7, following the close of...
-
Jun 30, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2014 earnings conference call on Thursday, July 31, at 8:00 a.m....
-
Jun 30, 2014Company Commits to Support Every Newborn Action Plan as Part of 2014 Partners' Forum
As a global medical technology company dedicated to its purpose of "Helping all people live healthy lives," BD (Becton, Dickinson and Company) (NYSE: BDX), is proud to announce its support for and...
-
Jun 25, 2014
SAN DIEGO, CA, June 25, 2014 /PRNewswire/ – The CareFusion Foundation today awarded $500,000 in grant funding to 11 U.S. nonprofit health care institutions as part of the Foundation's second...
-
Jun 18, 2014Company Commits to Support Every Newborn Action Plan as Part of 2014 Partners’ Forum
FRANKLIN LAKES, N.J., June 18, 2014 – BD (Becton, Dickinson and Company), a leading global medical technology company, has recognized eight suppliers for increasing BD’s customer satisfaction...
-
Jun 18, 2014MicroLap Line Helps Achieve Virtually Scar-less Surgeries
SAN DIEGO, June 18, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced the commercial launch of its new micro-laparoscopic line of surgical...
-
Jun 17, 2014First Healthcare Institution in the U.S. to Implement the System
BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an agreement with The University of Texas MD Anderson Cancer...
-
Jun 16, 2014New Version of Guardrails® Suite MX Safety Software Helps Improve Medication Safety
TORONTO, June 16, 2014 – CareFusion (NYSE:CFN), a leading global medical technology company, today announced the Canadian launch of the Alaris® System to help improve IV medication safety. The...
-
Jun 11, 2014The BD BACTEC(TM) FX40 Blood Culture Instrument now communicates with the BD EpiCenter(TM) Data Management System, enabling Laboratory Information System connectivity and Blood Volume Monitoring
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its launch of the BD BACTEC(TM) FX40 Blood Culture System...
-
Jun 6, 2014BD enters into an agreement with AITbiotech Pte Ltd for the distribution of AITbiotech abTES™ BM qPCR assays optimized on the BD MAX™ System
Singapore, June 6, 2014 – BD has announced through its Singapore-based subsidiary, Becton Dickinson Holdings Pte Ltd, the signing of a distribution agreement with AITbiotech Pte Ltd, a leading...
-
Jun 5, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the publication of its 2013 Sustainability Report. This is BD's sixth annual...
-
Jun 2, 2014Data To Be Presented on Improving Cleansing Compliance Through StartClean Cleansing Program
SAN DIEGO, June 2, 2014 /PRNewswire/ – At the 41st Annual Conference of the Association for Professionals in Infection Control and Epidemiology (APIC), CareFusion (NYSE:CFN), a leading global...
-
May 29, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following investor healthcare conferences in June 2014:...
-
May 20, 2014Startups can apply now for the Microsoft Ventures Accelerator in Tel Aviv
TEL AVIV, Israel, May 20, 2014 – For the first time in the Israeli market, two major corporations will cooperate to help identify potential breakthrough startups. Microsoft and BD (Becton,...
-
May 20, 2014BD Signs Agreement with Island Health to Install Microbiology Platform by Fourth Quarter 2014
MISSISSAUGA, ONTARIO, May 20, 2014 – BD (Becton, Dickinson and Company), a leading global medical technology company, today announced an agreement with Island Health to install the BD Kiestra™...
-
May 20, 2014
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 54.5 cents per common share payable on June 30, 2014 to holders of record on June 9,...
-
May 15, 2014
SAN DIEGO, CA, May 15, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today announced the successful pricing of three series of senior unsecured...
-
May 14, 2014BD Medical - Medical Surgical Systems and BD Medical - Pharmaceutical Systems sites in Columbus push to close skills gap needed by local industry
COLUMBUS, NE, May 14, 2014 – BD Medical, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, has awarded $12,000 in scholarships to three local high...
-
May 13, 2014Data-driven approach and implementation of BD Vacutainer® Push Button Blood Collection Sets help drive change at Robert Wood Johnson University Hospital
An article published in the Spring 2014 issue of the Journal of the Association of Occupational Health Professionals in Healthcare discusses how a systematic, data-driven approach and the...
-
May 12, 2014BD MAX™ Enteric Parasite Panel Achieves CE Mark to Detect Common and Pathogenic Intestinal ParasitesSupports comprehensive screening for infectious gastroenteritis with the BD MAX™ System
SPARKS, MD, May 12, 2014 – BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company), announced today the availability of the CE-marked BD MAX™ Enteric...
-
May 8, 20142,000 sq. ft. interactive laboratory environment expansion funded by BD Diagnostics
BALTIMORE, MD, May 8, 2014 – The Maryland Science Center’s newly expanded and re-imagined space, SciLab, is now open, providing a unique, popular and hands-on laboratory science simulation for...
-
May 7, 2014Move Increases Size of Board to 10 Members
SAN DIEGO, CA, May 7, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced that Supratim Bose has been elected as the 10th member of its board...
-
May 7, 2014
BD Diagnostics, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), announced today the availability of the FDA-cleared BD MAX(TM) Enteric...
